IL2 and benign prostatic hyperplasia: However, we did not see any significant difference in IFN-γ or IL-2 expression by qRT-PCR in PBMCs from either BPH or PCa patients (Supplementary Figure S1), suggesting that inflammation in tissues is important to consider.